22nd Apr 2013 11:52
RNS Number : 9006C
ValiRx PLC
22 April 2013
ValiRx plc
("ValiRx" or the "Company")
Result of AGM
ValiRx (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.
Enquiries:
ValiRx plc Dr Satu Vainikka | Tel: +44 (0)20 3008 4416 www.ValiRx.com |
|
|
Cairn Financial Advisers LLP (Nominated Adviser) Liam Murray / Avi Robinson | Tel: +44 (0)20 7148 7900 |
|
|
Hybridan LLP (Broker) Claire Noyce/Deepak Reddy | Tel: + 44 (0)20 7947 4350
|
|
|
Peckwater PT Tarquin Edwards | Tel: +44 (0)7879 458 364 tarquin.edwards@peckwaterpr.co.uk |
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
ValiRx